Natalia Izabela Szczęsny

Natalia Izabela Szczęsny

Auto-generated profile, based on publicly available information

Natalia Izabela Szczęsny

Faculty of Medical Sciences and Health Sciences, Kazimierz Pułaski University of Technology and Humanities, Radom, Poland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2023 in Journal of Pre-Clinical and Clinical Research
Verified
Journal Article
Open access
WNWeronika Nowak
Weronika Nowak
PZPatrycja Znamirowska
Patrycja Znamirowska
NSNatalia Szmigielska
Natalia Szmigielska
KZKatarzyna Zemsta
Katarzyna Zemsta
JMJoanna Miśkiewicz
Joanna Miśkiewicz
BKBartłomiej Kulesza
Bartłomiej Kulesza
Introduction and objective: Carpal tunnel syndrome (CTS) is a common condition characterized by the compression of the median nerve in the wrist. Left untreated, it leads to significant discomfort and loss of motor function in the hand. The aim of this systematic review is to identify and...

23 September 2023 in Medical Science Monitor
Verified
Journal Article
Open access
SPSzymon Piatek
Szymon Piatek
NSNatalia Szczęsny
Natalia Szczęsny
ISIwona Szymusik
Iwona Szymusik
KKKarolina Karoń
Karolina Karoń
KPKrzysztof Piątkowski
Krzysztof Piątkowski
MGMariusz Gujski
Mariusz Gujski
Gestational choriocarcinoma (GC) is an uncommon neoplasia that occurs in women who may not have completed a procreation plan. The aim of this study was to evaluate oncological and obstetrical outcomes in young patients with GC after fertility-sparing treatment. The eligibility criteria for the study were histopathological diagnosis of GC, age ≤40 years, and treatment with systemic chemotherapy. Patients who underwent upfront hysterectomy were excluded. The response to treatment was assessed according to beta-human chorionic gonadotropin (beta-hCG) serum measurement. Complete response and progression were considered if the beta-hCG dropped to a normal range and increased (or reached a plateau), respectively. The birth rate was calculated as the number of women who gave birth after treatment divided by the total number of patients. A total of 18 patients fulfilled the study’s eligibility criteria. A complete response and progression to first-line chemotherapy were found in 13 (72.22%) and 5 (27.78%) patients, respectively. Salvage treatment was administered to patients with progression. Overall, 16 (88.88%) patients achieved complete response after treatment and 2 (11.12%) died. GC relapse was diagnosed in 1 patient 62 months after treatment. The birth rate was 22.22%, and a total of 6 children were born. All pregnancies ended in term delivery. No congenital abnormalities were detected in the newborns. GC is a life-threatening form of gestational trophoblastic neoplasia, mainly due to its rapid course and resistance to chemotherapy. Most patients with GC will not be able to bear children after treatment.

19 July 2024 in Journal of Pre-Clinical and Clinical Research
Verified
Journal Article
Open access
NSNatalia Izabela Szczęsny
Natalia Izabela Szczęsny
KKKarolina Karoń
Karolina Karoń
EBEwelina Bornio
Ewelina Bornio
KPKrzysztof Piątkowski
Krzysztof Piątkowski
WGWojciech Krzysztof Grabowski
Wojciech Krzysztof Grabowski
SPSzymon Piatek
Szymon Piatek
Benign metastasizing leiomyoma (BML) is a rare condition predominantly affecting women of late reproductive age, characterized by metastasis of the uterine leiomyomas to distant organs. The case is presented of a 48-year-old woman with BML who initially presented with non-specific abdominal pain....